External-applied medicine for treating hyperosteogeny

Abstract

The invention relates to a medication for external use and treating hyperosteogeny, which belongs to the technical field of medicine. According to weight ratio, the components of the medication for external use and treating hyperosteogeny are fresh rhizoma zingiberis recens 7.5-9 parts, white mustard seed 0.3-1 part, nux vomica 0.5-0.9 part and pangolin scales 0.5-1 part. The producing method is that firstly to weigh proportionally white mustard seed, nux vomica and rhizoma zingiberis recens, then to process into fine powder and fully mix up, then to weigh proportionally rhizoma zingiberis recens and grind, finally to mix the rhizoma zingiberis recens and the mixture fully. The invention relates to a medication for external use and treating hyperosteogeny, of which the Chinese traditionalherb components are combined reasonably, the contents are proper, and the components act in good synergy with each other, thereby, the invention has good effects of warming and freeing channels, promoting Qi flow and resolving hard masses, promoting blood circulation and eliminating mass, reducing and removing edema, relieving pain, resisting inflammation and the like. Further, the component of rhizoma zingiberis recens concocts medical adhesive effect. Simultaneously, with the usage of relieving exterior syndrome and sweating effect of rhizoma zingiberis recens, the active ingredients of themedication can rapidly reach focal positions, thereby the cure object is achieved, patients can recover as soon as possible, and the pain thereof is reduced.

Description

1. Technical field [0001] The invention relates to an external medicine for treating hyperosteogeny, belonging to the technical field of medicines. 2. Background technology [0002] Bone hyperplasia refers to the increase of bone trabeculae and bone density at the edge of the vertebra or the edge of the joint, the articular surface and the bony prominence. Commonly known as bone spurs. Its main pathological changes are degenerative changes of articular cartilage, bony spurs on joint edges, and thickened synovium in the joint cavity. It is often accompanied by symptoms such as inflammation or purulence. Knees, spine, fingers, heels, etc. In daily life, it is often seen that some middle-aged and elderly people are worried after suffering from hyperosteogeny, thinking that hyperosteogeny is an incurable disease that can cause paralysis, and they spend a lot of money seeking medical treatment for this disease. It requires us to have a correct understanding of bone hyperplasia...

AI Technical Summary

Problems solved by technology

[0003] At present, drugs for the treatment of hyperosteogeny are generally divided into internal or external use, both of which have certain clinical curative effects, but long-term use of internal drugs can stimulate the stomach and easily cause other lesions, especially simple pain-relieving drugs. Symptoms can be relieved, but it can’t cure the root cause, or even aggravate the condition, delaying the best treatment time. As for external use, plasters are mostly used, but the curative effect is not satisfactory, and few patients can avoid recurrence after stopping the medicine.